FDA Inspection
Eosera, Inc.Eosera, Inc. – FDA Inspection, Mar 1, 2022
Record Details
This FDA Inspection record concerns Eosera, Inc., with an inspection on March 1, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Eosera, Inc.
- Inspection Date
- March 1, 2022
- Product Type
- Drugs
View Company Profile
ID · 809c8c78-0695-434f-9552-a3a9c12e8c0c
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1165791
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Eosera, Inc.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| March 20, 2026 | Not classified | Dallas District Office | Drug Quality Assurance |
| April 28, 2025 | Not classified | Dallas District Office | Drug Quality Assurance |
| January 17, 2020 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Eosera, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.